Febuxostat: a safe and effective therapy for hyperuricemia and gout

By Jordan Natasha   McCarthy Geraldine M  

Future Rheumatology, Vol. 1, Iss. 3, 2006-06 ,pp. : 303-309

Future Medicine

Access to resources Recommend Favorite

The degree of asymptomatic hyperuricemia and the risk of gout. A retrospective analysis of a large cohort

By Duskin-Bitan Hadar   Cohen Eytan   Goldberg Elad   Shochat Tzippy   Levi Amos   Garty Moshe   Krause Ilan  

Clinical Rheumatology, Vol. 33, Iss. 4, 2014-04 ,pp. : 549-553

Springer Publishing Company

Access to resources Recommend Favorite

ANCA-positive pauci-immune glomerulonephritis and febuxostat treatment

By Izzedine Hassane   Boulanger Henri   Gueutin Victor   Rouvier Philippe   Deray Gilbert  

Clinical Kidney Journal, Vol. 5, Iss. 5, 2012-10 ,pp. : 486-486

Oxford University Press

Access to resources Recommend Favorite

What have the Framingham cohorts taught us about hyperuricemia and gout?

By Bhole Vidula   Krishnan Eswar  

International Journal of Clinical Rheumatology, Vol. 8, Iss. 2, 2013-04 ,pp. : 149-151

Future Medicine

Access to resources Recommend Favorite

Effect of the Treatment with Allopurinol on the Endothelial Function in Patients with Hyperuricemia

By Meléndez-Ramírez Gabriela   Pérez-Méndez Oscar   López-Osorio Cristhel   Kuri-Alfaro Jorge   Espinola-Zavaleta Nilda  

Endocrine Research, Vol. 37, Iss. 1, 2012-02 ,pp. : 1-6

Informa Healthcare

Access to resources Recommend Favorite